z-logo
open-access-imgOpen Access
Antibody persistence and safety 3 years after CYD tetravalent dengue vaccination: follow-up results from a phase I trial in the Philippines
Author(s) -
María Rosario Capeding,
Anh Wartel,
Mark Boaz,
Thelma Laot,
Denis Crevat
Publication year - 2012
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2012.05.984
Subject(s) - dengue fever , medicine , dengue vaccine , vaccination , immunogenicity , titer , neutralizing antibody , regimen , antibody , immunology , virology , dengue virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom